2-(4-bromophenyl)-1-(piperazin-1-yl)ethan-1-one TFA salt
95%
- Product Code: 64513
CAS:
954582-52-6
| Molecular Weight: | 381.19 g./mol | Molecular Formula: | C₁₄H₁₆BrF₃N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of biologically active molecules. It serves as a key intermediate in the creation of compounds targeting central nervous system disorders, such as anxiety and depression, due to its structural compatibility with receptors in the brain. Additionally, it is employed in the development of potential therapeutic agents for cardiovascular diseases, leveraging its ability to interact with specific enzyme systems. Its application extends to the study of receptor-ligand interactions, aiding in the design of novel drugs with improved efficacy and selectivity.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White solid |
| PURITY | 94.5-100 |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿7,880.00 |
+
-
|
| 1.000 | 10-20 days | ฿15,520.00 |
+
-
|
| 5.000 | 10-20 days | ฿20,230.00 |
+
-
|
| 25.000 | 10-20 days | ฿71,640.00 |
+
-
|
2-(4-bromophenyl)-1-(piperazin-1-yl)ethan-1-one TFA salt
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of biologically active molecules. It serves as a key intermediate in the creation of compounds targeting central nervous system disorders, such as anxiety and depression, due to its structural compatibility with receptors in the brain. Additionally, it is employed in the development of potential therapeutic agents for cardiovascular diseases, leveraging its ability to interact with specific enzyme systems. Its application extends to the study of receptor-ligand interactions, aiding in the design of novel drugs with improved efficacy and selectivity.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :